Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Laufer

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Journal of Virology|May 15, 2009
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithmMelissa D Simek, Wasima Rida, Frances H Priddy, et al.
Cancer Discovery|April 21, 2021
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced DiseaseAmy C Mandigo, Wei Yuan, Kexin Xu, et al.
STAR Protocols|September 21, 2023
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humansLarissa L S Scholte, David J Leggat, Kristen W Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic StrategiesEmanuela Dylgjeri, Christopher McNair, Jonathan F Goodwin, et al.
Annals of Internal Medicine|February 3, 2016
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized TrialLindsey R Baden, Etienne Karita, Gaudensia Mutua, et al.
Kidney360|April 14, 2022
Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient HemodialysisAna Cecilia Bardossy, Lauren Korhonen, Sabrina Schatzman, et al.
Science Translational Medicine|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responsesKristen W Cohen, Stephen C De Rosa, William J Fulp, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
NPJ Vaccines|March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Science Translational Medicine|July 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trialK Rachael Parks, Zoe Moodie, Mary A Allen, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Journal of Virology|May 15, 2009
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithmMelissa D Simek, Wasima Rida, Frances H Priddy, et al.
Cancer Discovery|April 21, 2021
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced DiseaseAmy C Mandigo, Wei Yuan, Kexin Xu, et al.
STAR Protocols|September 21, 2023
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humansLarissa L S Scholte, David J Leggat, Kristen W Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic StrategiesEmanuela Dylgjeri, Christopher McNair, Jonathan F Goodwin, et al.
Annals of Internal Medicine|February 3, 2016
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized TrialLindsey R Baden, Etienne Karita, Gaudensia Mutua, et al.
Kidney360|April 14, 2022
Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient HemodialysisAna Cecilia Bardossy, Lauren Korhonen, Sabrina Schatzman, et al.
Science Translational Medicine|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responsesKristen W Cohen, Stephen C De Rosa, William J Fulp, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
NPJ Vaccines|March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Science Translational Medicine|July 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trialK Rachael Parks, Zoe Moodie, Mary A Allen, et al.
Pageof 13